Results 31 to 40 of about 8,564,356 (290)
Brazilian Journal of Nephrology, 2022 Introduction: Sensitization to human leukocyte antigen is a barrier to. Few data have been published on desensitization using polyvalent human intravenous immunoglobulin (IVIG) alone.
Luiz Roberto de Sousa Ulisses +9 more
doaj +2 more sources
Isotype specific ELISAs to detect antibodies against swine vesicular disease virus and their use in epidemiology [PDF]
, 2002 Isotype specific ELISAs to detect antibodies against swine vesicular disease, which may help to estimate the moment of infection, were developed and validated on sera from pigs experimentally infected with four different isolates of swine vesicular ...
Dekker, A. +3 more
core +1 more source
, 2022 Chronic active antibody-mediated rejection is the leading cause of kidney transplant failure. Although various immunosuppressive agents have been tested, rituximab included, presently there is no effective treatment.
Giannopoulou M., Tarassi K., Tsouka G., Christodoulidou C., Stefanidis I., Eleftheriadis T.
core +1 more source
The role of nonadherence in donor-specific antibodies formation and their effects on kidney transplant function [PDF]
Srpski Arhiv za Celokupno LekarstvoIntroduction. Antibody-mediated rejection is one of the leading causes of graft loss after kidney transplant. Donor-specific antibodies (DSAs) are recognized as biomarkers of transplant rejection.
Petrović Lada +4 more
doaj +1 more source
Frontiers in Genetics, 2022 The single antigen bead (SAB) assay is the most used test for the identification of HLA specific antibodies pre- and post-transplant. Nevertheless, detection of spurious reactivities remains a recognized assay limitation.
Robert S. Liwski +5 more
doaj +1 more source
Donor-specific antibodies development in renal living-donor receptors: Effect of a single cohort
International Journal of Immunopathology and Pharmacology, 2021 Minimization in immunosuppression could contribute to the appearance the donor-specific HLA antibodies (DSA) and graft failure. The objective was to compare the incidence of DSA in renal transplantation (RT) in recipients with immunosuppression with and ...
Jorge Andrade-Sierra +13 more
doaj +1 more source
Frontiers in Medicine, 2022 Seroconversion rates after COVID-19 vaccination are significantly lower in kidney transplant recipients compared to healthy cohorts. Adaptive immunization strategies are needed to protect these patients from COVID-19.
Louise Benning +23 more
doaj +1 more source
Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies
Experimental and Clinical Transplantation, 2019 We investigated outcomes in living-donor kidney transplant recipients with preformed donor-specific antibodies (detected with flow cytometry and specified with the LABScreen single antigen test) under desensitization pretransplant and immunosuppression posttransplant.Of 15 recipients included, 8 had ABO-incompatible kidney transplant.
Yoshihiro, Itabashi +13 more
openaire +2 more sources
BMC Pulmonary Medicine, 2018 Background Previous studies have suggested that antibodies against human leukocyte antigen (HLA) are associated with worse outcomes in lung transplantation.
Ji Eun Park +7 more
doaj +1 more source
Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients [PDF]
Annals of Surgical Treatment and Research, 2015 Preformed circulating donor-specific antibodies (DSAs) immunologically challenge vascular endothelium and the bile duct. However, the liver is an immune-tolerant organ and can avoid immunological challenges. This study was undertaken to analyze the effects of DSAs after adult living donor liver transplantation (LDLT).We retrospectively reviewed 219 ...
Song, Seung Hwan +9 more
openaire +3 more sources